Denmark Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Denmark Pharmaceutical Companies and the market is segmented by ATC/Therapeutic Class (Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular System, Dermatologicals Drugs, Genitourinary System and Reproductive Hormones, Systemic Hormonal Preparations, excluding Reproductive Hormones and Insulin, Anti-infectives for Systemic Use, Antineoplastic and Immunomodulating Agents, Musculoskeletal System, Nervous System, Antiparasitic Products, Insecticides, and Repellents, Respiratory System, Sensory Organs, and Various ATC Structures), Sector (Primary Sector, and Hospital Sector), and Prescription Type (Prescription Drugs and OTC). The report offers the value (in USD million) for all the above segments.

Denmark Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Denmark Pharmaceutical Industry Overview

The pharmaceutical industry is competitive and consists of several major players in Denmark having a major focus on research and development. Some of the major pharmaceutical companies in the country are Novo Nordisk A/S, H. Lundbeck A/S, Leo Pharma A/S, Orifarm Group A/S, ALK-Abell贸 A/S, Xellia ApS, Takeda Pharma A/S, Sandoz A/S, Ferring Pharmaceuticals A/S, and FUJIFILM Diosynth Biotechnologies

Denmark Pharmaceutical Market Leaders

  1. Novo Nordisk A/S

  2. Leo Pharma A/S

  3. H. Lundbeck A/S

  4. Orifarm Group A/S

  5. ALK-Abell贸 Nordic A / S

  6. *Disclaimer: Major Players sorted in no particular order
Novo Nordisk A/S, Leo Pharma A/S, H. Lundbeck A/S, Orifarm Group A/S, ALK-Abell贸 Nordic A / S